Jump to content
RemedySpot.com

Summary -Viruses in CFS conference, June 23-24th, 2008

Rate this topic


Recommended Posts

Posted

Reference: *HHV-6 & -7 -Summary 6th

International Conference*; Help ME Circle,

8 October 2008; at Co-Cure:

http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind0810b & L=co-cure & T=0 & F= & S= & P=836

Summary of the Viruses in CFS

conference, June 23-24th, 2008

By Komaroff, MD

The Viruses in Chronic Fatigue Syndrome & Post-Viral

Fatigue Conference was held in Baltimore, land,

on June 22-23, 2008. Investigators from around the

world examined evidence for the possible role of

several different viruses in initiating and

perpetuating chronic fatigue syndrome (CFS).

Post-Infectious Fatigue Syndrome (PIFS)

For over 60 years, scientists have reported sporadic

cases of a chronic fatiguing illness developing in the

wake of a well-documented infection. Nevertheless,

it is only in the last few years that scientists have

systematically studied this PIFS. These studies have

begun by identifying all cases of a well-documented

type of infection in a large group of people. Then,

the research team carefully follows the patients for a

long time thereafter, evaluating symptoms, and

performing physical examinations and laboratory

testing.

In 2006, a landmark study of post-infectious fatigue

syndrome that was conducted in Dubbo, Australia,

was published. The team studied people with each of

three different kinds of infections—Epstein-Barr virus

infection, Ross River virus infection, and infection

with a bacterium, iella burnetii, the cause of a

disease called Q fever. The study showed that about

10% of patients in each of the three groups

developed a post-infectious fatigue syndrome that

met the Centers for Disease Control and Prevention

(CDC) criteria for CFS.

At the Conference, the team reported in detail on

this study. The chronic illness was most likely to

develop in those patients who were sickest at the

time of the initial infection: demographic,

psychological and microbiological factors did not

predict who would develop PIFS. Although final

results were not presented, the team reported that

the activity of a handful of genes predicted who

would become most severely ill with PIFS, and that

genes were plausible candidates to explain the

symptoms of PIFS. In particular, the team found

variations in the genes for two immune system

chemicals that affect inflammation

(cytokines)—interferon-y (gamma) and

interleukin-10.

Human Herpesvirus-6 (HHV-6) and HHV-7

For almost 20 years, studies have found evidence

associating HHV-6 with chronic fatigue syndrome

(CFS). Most human beings are permanently infected

with HHV-6, although the virus usually remains

" asleep " (inactive) inside certain cells and is not

making copies of itself. However, sometimes the

virus " reawakens " and begins to multiply—a

condition called active infection.

Any human being with an inactive infection—which is

to say, most human beings—will have detectable

antibodies against the virus in their blood. People

with active infections can be identified by tests of

antibodies, virus antigens, and viral nucleic acids in

the blood. Most researchers who have studied it

report that patients with CFS more often have active

infection with HHV-6 than either healthy people or

people with other illnesses than can cause fatigue.

At the Barcelona Conference in 2006, a preliminary

study reported that patients with CFS and evidence

of active infection with HHV-6 and/or a related virus,

Epstein-Barr virus, improved when treated with an

antiviral drug, valganciclovir (Valcyte®). However,

that study did not give some patients the antiviral

drug and other patients a placebo (i.e., sugar pill),

and so it could not prove that the treatment actually

helped .

At the Baltimore Conference, the same group from

Stanford University reported on a randomized,

placebo-controlled trial. The study had ended just

before the conference began, and only a small

amount of the data had been analyzed. The patients

who received the valganciclovir seemed to improve

more than the patients given placebo, but further

analysis of the data is required to determine the

results of the study.

A team from Latvia reported that latent (inactive)

infection with HHV-7 was present more often in

patients with CFS than in healthy control subjects.

The team also found that active infection with HHV-6

was present in many more patients with CFS than in

healthy control subjects.

Epstein-Barr Virus

In the mid-1980's, some cases of (what came to be

called) CFS were associated with reactivated

Epstein-Barr virus (EBV) infection.

At the Baltimore Conference, one team reported that

a protein made by EBV during active infection

stimulates the production of several cytokines. These

cytokines can produce many of the symptoms of CFS.

The team reported that the mechanism by which EBV

induces the production of these cytokines is through

triggering an immune system " master switch " called

NF-kB (kappaB).

Parvovirus

PIFS following infection with parvovirus B19 has been

reported for more than a decade. A team from Japan

followed over 200 patients immediately after they

had been infected with the virus. PIFS was not

associated with continued presence of viral DNA in

the blood, but levels of complement—proteins

involved in inflammation—were.

Another study found that people experiencing a lot of

stress at the time they developed a new infection

with parvovirus were more likely to go on to develop

a PIFS that met criteria for CFS. In addition, as was

found in the Dubbo study (above), patients whose

immune system cells produced high levels of

inflammatory cytokines at the time of initial infection

were also more likely to go on to develop a PIFS.

Enteroviruses

Enteroviruses include three families of human

viruses: sackievirus, echovirus and poliovirus.

These viruses can infect the cells of the brain and

spinal cord, respiratory tract, muscle and gut cells,

and have been suspected as a possible cause of CFS

for many decades.

A research team reported finding enterovirus RNA

(viral genetic material) and high levels of antibodies

against enteroviruses more often in patients with

CFS than in healthy control subjects. Stomach

biopsies were performed in some patients with CFS

who had abdominal symptoms: enterovirus antigens

were found much more often in their stomach tissue

than in stomach tissue from patients who had

biopsies for reasons other than CFS (like possible

stomach ulcers). In patients with enterovirus

antigens in the stomach, enterovirus RNA was also

found.

Borna disease virus

Borna disease virus has long been recognized to

infect animals that are in close contact with

humans—horses, cattle, dogs and cats. It causes

infection of the brain, particularly the limbic system,

which is involved in emotion, behavior, and

long-term memory. A team from Germany reported

the latest research from its laboratory indicating that

the virus also can infect humans, and may cause

various mood disorders.

The team reported that it had isolated Borna disease

virus from the blood of a U.S. patient with CFS. In

the test tube, they found that the virus was killed by

an antiviral drug called amantadine. They then found

that a German patient with CFS and evidence of

Borna disease virus infection improved clinically with

amantadine treatment.

A team from Japan reported finding evidence of

Borna disease virus in about 10% of patients with

CFS.

Endogenous retroviruses

Nested among each of our genes are sequences of

DNA that may make viruses called endogenous

retroviruses. These DNA segments have been

inherited from our parents, and entered the human

genome millions of years ago. Most of them are

thought to be unable to actually make retroviruses.

One research team reported that a particular

endogenous retrovirus called human endogenous

retrovirus-K18 (HERV-K18) can be induced to make

viruses when a cell is infected with Epstein-Barr virus

or stimulated by a chemical called interferon-a

(which is both a natural chemical and a drug used to

treat various diseases). Three different variants of

HERV-K18 exist. The team reported that one variant,

K18.3, is found more often in patients with CFS.

The possibility that HERV-K18 might trigger CFS in

some people is plausible: HERV-K18 makes a protein

called a " superantigen " that triggers a strong

immune response and dysregulates the immune

system. Such a response could theoretically trigger

the symptoms of CFS. This research is preliminary,

but intriguing.

Immunological and genetic studies

Gene polymorphisms.

Contemporary biology allows scientists to do

something that was impossible only 30 years ago: to

easily identify gene variations. Some genes exist in

several subtly different forms, called polymorphisms.

The polymorphisms were caused by a mutation,

typically one that occurred in a distant ancestor and

was passed on to future generations. Tiny mutations

in a gene can change the function of the protein

made by the gene, and that can lead to disease.

A team using genetic data collected by the CDC

reported that several polymorphisms in genes that

are part of the brain hormone system

( " neuroendocrine system " ) are found much more

often in people with CFS. It is well known that the

brain hormone system " talks " to the immune system,

through various chemical signals. The team showed

that the communication between these two systems

was quite different in patients with CFS than in

healthy control subjects.

Gene expression studies.

Contemporary biology also allows scientists to do

something else that was impossible only 20 years

ago: to identify every gene in a cell, and determine if

it is turned on or off. Genes that are turned on are

said to be " expressed " : they are making the protein

that they were built to make. For example, scientists

can take a group of cells—like white blood cells in

patients with a particular disease, or diseased tissue

(such as a particular type of cancer)—and see which

of the roughly 22,000 human genes are being

expressed, and which are not: a " gene expression

fingerprint " .

A research team from England reported that 88

genes (out of the approximately 22,000 human

genes) were uniquely expressed in the white blood

cells of patients with CFS: 85 genes were turned on,

and 3 were turned off. The 88 genes typically

involved biological functions that are central to the

immune response to infection—which is consistent

with the idea that CFS can be triggered and/or

perpetuated by certain infections.

Immunological abnormalities and symptoms.

One presentation summarized the immunological

measurements that distinguish patients with CFS

from healthy controls, including: increased numbers

of activated T cells (a type of white blood cell);

impaired function of T cells and natural killer cells

(NK cells), another type of white blood cell; TH2

cytokine shift (a change in the type of cytokines

produced); increased levels and production of

inflammatory cytokines; reduced amounts of a

molecule called soluble CD26; and increased

amounts of a molecule called NPY. But did these

measurable abnormalities have any connection to the

symptoms that patients with CFS were experiencing?

Data were presented indicating that diminished T cell

and NK cell function correlate with cognitive

impairment and reduced level of function.

Summary

CFS was named and defined only 20 years ago,

although a similar illness had been described in the

medical literature for hundreds of years. The

possibility that CFS is often triggered by infectious

agents has been widely discussed and debated. Few

scientists have argued that a single novel infectious

agent is responsible for CFS, in the way that HIV is

the central and necessary cause of AIDS. Indeed,

most illnesses caused by infectious agents can be

caused by multiple different types of infectious

agents. For example, bronchitis, gastroenteritis,

hepatitis, urinary infections, and the common cold

are each caused by multiple infectious agents.

This conference presented evidence that a handful of

infectious agents are plausible triggers of CFS. The

evidence was both direct—associations between an

infectious agent and CFS—and indirect—evidence of

an immune response in CFS that suggests the body

may be attempting to battle an infectious agent.

Altogether, both proponents and opponents of the

theory that CFS can be triggered by infectious agents

had much food for thought.

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...